Europe Influenza Vaccines Market
The Europe Influenza Vaccines Market size was valued at US$ 2,261.85 Mn in 2022 and is projected to reach US$ 3,424.02 Mn by 2028, growing at a CAGR of 7.2% during 2022 - 2028.
Report Coverage
- Vaccine Type: Quadrivalent Vaccines and Trivalent Vaccines
- Virus Type: Influenza Virus Type A and Influenza Virus Type B
- Technology: Egg-based and Cell-based
- Route of Administration: Injection and Nasal Spray
- Target Group: Infants, Children, Adults, Elderly People
US$ 2,261.85 Mn
Market size in 2022
US$ 3,424.02 Mn
Market Size by 2028
7.2%
CAGR, 2022 - 2028
2023-2028
Forecast Period
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Europe Influenza Vaccines Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Europe Influenza Vaccines Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Europe Influenza Vaccines Market Regional Analysis
6.2 Europe Influenza Vaccines Market Revenue 2020-2028 (US$ Million)
6.3 Europe Influenza Vaccines Market Forecast Analysis
7. Europe Influenza Vaccines Market Analysis – by Vaccine Type
7.1 Quadrivalent Vaccines and Trivalent Vaccines
- 7.1.1 Overview
- 7.1.2 Quadrivalent Vaccines and Trivalent Vaccines: Europe Influenza Vaccines Market – Revenue and Forecast, 2020-2028 (US$ Million)
8. Europe Influenza Vaccines Market Analysis – by Virus Type
8.1 Influenza Virus Type A and Influenza Virus Type B
- 8.1.1 Overview
- 8.1.2 Influenza Virus Type A and Influenza Virus Type B: Europe Influenza Vaccines Market – Revenue and Forecast, 2020-2028 (US$ Million)
9. Europe Influenza Vaccines Market Analysis – by Technology
9.1 Egg-based and Cell-based
- 9.1.1 Overview
- 9.1.2 Egg-based and Cell-based: Europe Influenza Vaccines Market – Revenue and Forecast, 2020-2028 (US$ Million)
10. Europe Influenza Vaccines Market Analysis – by Route of Administration
10.1 Injection and Nasal Spray
- 10.1.1 Overview
- 10.1.2 Injection and Nasal Spray: Europe Influenza Vaccines Market – Revenue and Forecast, 2020-2028 (US$ Million)
11. Europe Influenza Vaccines Market – Europe Analysis
11.1 Overview
11.2 Europe- 11.2.1 Europe Influenza Vaccines Market Breakdown, by Key Country, 2023 and 2028 (%)
- 11.2.1.1 Europe Influenza Vaccines Market – Revenue and Forecast Analysis – by Country
- 11.2.1.1 UK: Europe Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
- 11.2.1.1.1 UK: Europe Influenza Vaccines Market Breakdown, by Vaccine Type
- 11.2.1.1.2 UK: Europe Influenza Vaccines Market Breakdown, by Virus Type
- 11.2.1.1.3 UK: Europe Influenza Vaccines Market Breakdown, by Technology
- 11.2.1.1.4 UK: Europe Influenza Vaccines Market Breakdown, by Route of Administration
- 11.2.1.2 Germany: Europe Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
- 11.2.1.2.1 Germany: Europe Influenza Vaccines Market Breakdown, by Vaccine Type
- 11.2.1.2.2 Germany: Europe Influenza Vaccines Market Breakdown, by Virus Type
- 11.2.1.2.3 Germany: Europe Influenza Vaccines Market Breakdown, by Technology
- 11.2.1.2.4 Germany: Europe Influenza Vaccines Market Breakdown, by Route of Administration
- 11.2.1.3 France: Europe Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
- 11.2.1.3.1 France: Europe Influenza Vaccines Market Breakdown, by Vaccine Type
- 11.2.1.3.2 France: Europe Influenza Vaccines Market Breakdown, by Virus Type
- 11.2.1.3.3 France: Europe Influenza Vaccines Market Breakdown, by Technology
- 11.2.1.3.4 France: Europe Influenza Vaccines Market Breakdown, by Route of Administration
- 11.2.1.4 Russia: Europe Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
- 11.2.1.4.1 Russia: Europe Influenza Vaccines Market Breakdown, by Vaccine Type
- 11.2.1.4.2 Russia: Europe Influenza Vaccines Market Breakdown, by Virus Type
- 11.2.1.4.3 Russia: Europe Influenza Vaccines Market Breakdown, by Technology
- 11.2.1.4.4 Russia: Europe Influenza Vaccines Market Breakdown, by Route of Administration
- 11.2.1.5 Italy: Europe Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
- 11.2.1.5.1 Italy: Europe Influenza Vaccines Market Breakdown, by Vaccine Type
- 11.2.1.5.2 Italy: Europe Influenza Vaccines Market Breakdown, by Virus Type
- 11.2.1.5.3 Italy: Europe Influenza Vaccines Market Breakdown, by Technology
- 11.2.1.5.4 Italy: Europe Influenza Vaccines Market Breakdown, by Route of Administration
- 11.2.1.6 Rest of Europe: Europe Influenza Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
- 11.2.1.6.1 Rest of Europe: Europe Influenza Vaccines Market Breakdown, by Vaccine Type
- 11.2.1.6.2 Rest of Europe: Europe Influenza Vaccines Market Breakdown, by Virus Type
- 11.2.1.6.3 Rest of Europe: Europe Influenza Vaccines Market Breakdown, by Technology
- 11.2.1.6.4 Rest of Europe: Europe Influenza Vaccines Market Breakdown, by Route of Administration
12. Competitive Landscape
12.1 Heat Map Analysis
12.2 Company Positioning and Concentration
13. Industry Landscape
13.1 Overview
13.2 Market Initiative
13.3 Partnerships and Collaborations
13.4 Other Developments
14. Company Profiles
14.1 AstraZeneca
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 Emergent BioSolutions Inc.
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 GlaxoSmithKline plc.
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 Mitsubishi Chemical Group Corporation
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 Moderna, Inc.
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 MYLAN N.V.
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 Sanofi
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
14.8 SEQIRUS
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
14.9 Serum Institute of India Pvt. Ltd
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments
15. Appendix
15.1 About Business Market Insights
15.2 List of Abbreviations
Access the Full E Market Report
Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.
